Table 3.

Lung transplant outcomes.

	Patient 1	Patient 2	Patient 3	Patient 4	Patient 5	Patient 6
Age, sex	34, F	69, F	38, F	27, M	25, M	63, M
Lung pathology	Pulmonary fibrosis predominates	ILD (granuloma and lymphoid infiltrate), bronchiectasis	ILD	Chronic obstructive disease	Pulmonary fibrosis predominates	ILD
CVID-associated comorbidities	Liver disease	None	None	Enteropathy	Lymphoid hyperplasia	NRH, AIHA, ITP, lymphoid hyperplasia
Transplant procedure	Lung	Lung	Lung	Lung and heart	Lung and heart	Lung
Outcome	Died of hyperacute rejection within days	Died of acute rejection after 8 months	Died of acute rejection after 1 year	Died of chronic rejection after 5 years	Died of chronic rejection after 6 years	Alive 4 months post-transplant

ILD, interstitial lung disease; NRH, nodular regenerative hyperplasia; AIHA, autoimmune hemolytic anemia; ITP, Immune thrombocytopenic purpura.